Premier Anti-Aging Co., Ltd. (4934) AI Stock Analysis

• Market Cap: ¥6.80B
• Dividend Yield: N/A
• Average Volume (3M): 11.01K
• Price to Earnings (P/E): 14.6
• Beta (1Y): 1.01
• Revenue Growth: -19.42%
• EPS Growth: N/A
• Country: JP
• Employees: 229
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 46.82
• Shares Outstanding: 8,720,534
• 10 Day Avg. Volume: 8,960
• 30 Day Avg. Volume: 11,006
• PEG Ratio: -0.12
• Price to Book (P/B): 1.14
• Price to Sales (P/S): 0.47
• P/FCF Ratio: 5.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 35.5
• Revenue Forecast (FY): ¥15.75B

• Rating: 52 Neutral
• Price Target: ¥825.00 ▲(17.52% Upside)
• Action: Reiterated Date: 10/03/25
• Date: Action: Reiterated 10/03/25

The overall stock score is primarily impacted by the company's financial performance, which shows strengths in gross profit margin and balance sheet stability but is hindered by declining revenues and low profitability. Technical analysis indicates bearish momentum, further weighing down the score. Valuation is a relative strength, with a reasonable P/E ratio, but the lack of a dividend yield is a drawback.

Positive Factors

High Gross Margin

A 76.65% gross margin indicates durable product-level pricing power and low direct costs. High gross margins provide a structural cushion against sales volatility, support investment in marketing/R&D, and allow the company to maintain profitability even if operating expenses rise.

Conservative Balance Sheet

Low leverage (D/E 0.17) and a healthy equity ratio give the company financial flexibility. This conservative capital structure reduces insolvency risk, supports funding for strategic initiatives or downturns, and preserves optionality for M&A or reinvestment without stressing cash flows.

Improved Free Cash Flow Conversion

A marked improvement in free cash flow and FCF/net income ~0.98 demonstrates strong conversion of accounting profits to cash. Durable cash generation enhances the company’s ability to fund operations, pay down liabilities, and invest in long-term growth without relying on external financing.

Negative Factors

Declining Revenue

Sustained revenue decline (reported as -19.4% in the fundamentals and described as multi-year decline in income statement notes) erodes scale and reduces leeway to cover fixed costs. Continued top-line contraction undermines long-term margin improvement and constrains reinvestment and growth options.

Low Net Profit Margin

A net margin near 2.9% leaves little buffer against cost inflation or revenue shocks and limits retained earnings available for reinvestment. Over time, persistently thin net margins hamper the company’s ability to scale profitably and reduce resilience to competitive or macroeconomic pressures.

Weak Operational Margins / Efficiency

Low EBIT and EBITDA margins point to structural inefficiencies in operating the business. Without sustainable improvements in operating leverage or cost structure, the company may struggle to convert strong gross margins into meaningful operating profit, constraining long-term return on capital.

Premier Anti-Aging Co., Ltd. Business Overview & Revenue Model

Company Description

Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also involved on the information provision and consulting services related to anti-aging, beauty, and health; research on management and beauty of beauty clinics, etc.; and marketing research and collection and analysis of various information. The company was founded in 2009 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Premier Anti-Aging Co., Ltd. generates revenue primarily through the sale of its anti-aging skincare products and dietary supplements. The company employs a multi-channel distribution strategy, selling its products through e-commerce platforms, retail partnerships with beauty stores, and direct-to-consumer channels. Key revenue streams include online sales, wholesale partnerships with beauty retailers, and subscription services for regular customers. Additionally, the company may engage in strategic partnerships with dermatologists and beauty influencers to enhance its market presence and drive product visibility, contributing significantly to its earnings.

Premier Anti-Aging Co., Ltd. Financial Statement Overview

Summary

Premier Anti-Aging Co., Ltd. shows a strong gross profit margin and a stable balance sheet with low leverage. However, declining revenues and low net profit margins are concerning. Cash flow has improved, but operational efficiency needs enhancement to boost profitability.

Income Statement

Premier Anti-Aging Co., Ltd. has experienced declining revenue over the past few years, with a negative revenue growth rate of -7.23% in the most recent year. The gross profit margin remains strong at 76.65%, indicating efficient production processes. However, the net profit margin is low at 2.91%, reflecting challenges in controlling costs or increasing sales. The EBIT and EBITDA margins are also low, suggesting limited operational efficiency and profitability.

Balance Sheet

The company's balance sheet shows a stable debt-to-equity ratio of 0.17, indicating conservative leverage. The return on equity is moderate at 7.13%, suggesting reasonable profitability from shareholders' investments. The equity ratio is healthy, reflecting a solid capital structure with a good proportion of equity financing.

Cash Flow

Cash flow analysis reveals a significant improvement in free cash flow, with a growth rate of 'Infinity' due to a previous negative base. The operating cash flow to net income ratio is 0.49, indicating moderate cash generation relative to net income. The free cash flow to net income ratio is high at 0.98, suggesting effective conversion of profits into cash.

Breakdown	Jul 2025	Jul 2024	Jul 2023	Jul 2022	Jul 2021
Income Statement
Total Revenue	16.16B	20.36B	26.40B	33.91B	32.81B
Gross Profit	12.39B	16.10B	19.24B	26.63B	26.43B
EBITDA	916.00M	-627.00M	-432.24M	2.67B	4.71B
Net Income	471.00M	-1.48B	-733.97M	1.42B	2.79B
Balance Sheet
Total Assets	10.14B	11.00B	12.14B	12.30B	13.07B
Cash, Cash Equivalents and Short-Term Investments	4.66B	4.76B	4.67B	2.97B	6.06B
Total Debt	1.11B	2.44B	2.26B	1.41B	911.41M
Total Liabilities	3.53B	4.88B	4.53B	3.95B	6.17B
Stockholders Equity	6.61B	6.12B	7.61B	8.35B	6.90B
Cash Flow
Free Cash Flow	1.44B	-395.00M	1.64B	-3.53B	2.68B
Operating Cash Flow	1.47B	425.00M	2.42B	-3.32B	2.75B
Investing Cash Flow	-229.00M	-540.00M	-900.97M	-297.68M	-180.83M
Financing Cash Flow	-1.34B	183.00M	179.77M	501.62M	1.58B

Premier Anti-Aging Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 702.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4934, the sentiment is Positive. The current price of 702 is below the 20-day moving average (MA) of 739.65, below the 50-day MA of 717.98, and below the 200-day MA of 798.51, indicating a neutral trend. The MACD of 18.96 indicates Negative momentum. The RSI at 62.01 is Neutral, neither overbought nor oversold. The STOCH value of 84.64 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4934.

Premier Anti-Aging Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4933	71 Outperform	¥19.34B	7.98	―	0.91%	13.12%	27.53%
4918	68 Neutral	¥2.31B	6.66	―	―	12.96%	―
4925	63 Neutral	¥6.95B	10.29	―	2.38%	-0.79%	―
4936	63 Neutral	¥9.11B	24.70	―	2.65%	11.87%	-31.02%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
4926	58 Neutral	¥5.84B	24.38	―	1.68%	8.46%	―
4934	52 Neutral	¥6.80B	14.63	―	―	-19.42%	―

Premier Anti-Aging Co., Ltd. Corporate Events

Premier Anti-Aging Reports Decline in Q1 Financial Results

Premier Anti-Aging Co., Ltd. reported a decline in its financial performance for the first three months of the fiscal year ending July 31, 2026, with net sales dropping by 13.9% compared to the previous year. Despite the decrease in sales and profits, the company’s equity ratio improved slightly, indicating a stable financial position, although the outlook for the fiscal year remains cautious.

The most recent analyst rating on (JP:4934) stock is a Hold with a Yen743.00 price target. To see the full list of analyst forecasts on Premier Anti-Aging Co., Ltd. stock, see the JP:4934 Stock Forecast page.